NCT01758913View on ClinicalTrials.gov

Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants

NACompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Patent Ductus Arteriosus

Interventions

DRUG

Ibuprofen

To compare the efficacy, the side effects and the renal prostaglandin (PG) excretion between indomethacin and ibuprofen in extremely low birth weight (ELBW) infants.

Trial Locations (1)

60612

John H. Stroger, Jr. Hospital of Cook County, Chicago

All Listed Sponsors

collaborator

Cook County Health

OTHER_GOV

collaborator

China Medical University Hospital

OTHER

lead

Taipei Medical University Hospital

OTHER

NCT01758913 - Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants | Biotech Hunter | Biotech Hunter